PLAINTIFFS MOTION FOR PRELIMINARY INJUNCTION: IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ALABAMA , AMERICA’S FRONTLINE DOCTORS, et al., Plaintiffs, vs. XAVIER BECERRA, Secretary of the U.S. Department of Health and Human Services, et al., Defendants.

 

https://drive.google.com/file/d/1As2M6xYg8zNmMniJZSA0xtGljMYJHLbg/view?usp=sharing 

IN THE UNITED STATES DISTRICT COURT FOR
THE NORTHERN DISTRICT OF ALABAMA
AMERICA’S FRONTLINE DOCTORS, et al., Plaintiffs,
vs.
XAVIER BECERRA, Secretary of the U.S. Department of Health and Human Services, et al., Defendants.
Civil Action No. 2:21-cv-00702-CLM

PLAINTIFFS MOTION FOR PRELIMINARY INJUNCTION

CONCLUSION

Accordingly, and for all of the foregoing reasons, Plaintiffs move under Rule 65, Fed.R.Civ.P., for a preliminary injunction against Defendants enjoining them from continuing to authorize the emergency use of the so-called “Pfizer-BioNTech COVID-19 Vaccine,” “Moderna COVID-19 Vaccine” and the “Johnson & Johnson (Janssen) COVID-19 Vaccine” pursuant to their respective EUAs, and from granting full FDA approval of the Vaccines:

 
(i) for the under-18 age category;

 
(ii) for those, regardless of age, who have been infected with SARS-CoV-2 prior to vaccination; and

 
(iii) until such time as the Defendants have complied with their obligation to create and maintain the requisite “conditions of authorization” under Section 546 of the Food, Drugs and Cosmetics Act, 21 U.S.C. § 360bbb–3(e), thereby enabling Vaccine candidates to give truly voluntary, informed consent.

Dated: July 19, 2021.

REFERENCE:
Motion seeking immediate injunctive relief in Alabama Federal District Court to stop Emergency Use Authorization (EUA) of the experimental COVID-19 injections